Tos AG - Search Results

1

Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings.

Foa R, Meloni G, Guarini A, Vignetti M, Marchis D, Tosti S, Tos AG, Vischia F, Mandelli F, Gavosto F. Foa R, et al. Among authors: tos ag. Leukemia. 1992;6 Suppl 3:115S-116S. Leukemia. 1992. PMID: 1602806

2

Interleukin-2 may induce prolonged remissions in advanced acute myelogenous leukemia.

Meloni G, Foa R, Vignetti M, Guarini A, Fenu S, Tosti S, Tos AG, Mandelli F. Meloni G, et al. Among authors: tos ag. Blood. 1994 Oct 1;84(7):2158-63. Blood. 1994. PMID: 7919330 Free article. Clinical Trial.

3

Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors.

Foa R, Fierro MT, Raspadori D, Bonferroni M, Cardona S, Guarini A, Tos AG, di Celle PF, Cesano A, Matera L. Foa R, et al. Among authors: tos ag. Blood. 1990 Oct 1;76(7):1349-54. Blood. 1990. PMID: 2207312 Free article.

4

Cytokines in B-Cell Chronic Lymphocytic Leukemia.

Foa R, Tos AG, Francia di Celle P, Carbone A, Marchis D, Vischia F, Cignetti A, Guarini A. Foa R, et al. Among authors: tos ag. Leuk Lymphoma. 1991;5 Suppl 1:7-11. doi: 10.3109/10428199109103372. Leuk Lymphoma. 1991. PMID: 27463473

5

Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.

Foa R, Massaia M, Cardona S, Tos AG, Bianchi A, Attisano C, Guarini A, di Celle PF, Fierro MT. Foa R, et al. Among authors: tos ag. Blood. 1990 Jul 15;76(2):393-400. Blood. 1990. PMID: 2114936 Free article.

6

Lymphokine Activated Killer (LAK) Cells Inhibit the in vitro Growth of Myeloid and Erythroid Progenitor Cells Via the Release of Tumor Necrosis Factor-Alphadagger.

Bellone G, Fierro MT, Liao XS, Tos AG, Bonferroni M, Pegoraro L, Foa R. Bellone G, et al. Among authors: tos ag. Leuk Lymphoma. 1990;1(5-6):341-52. doi: 10.1080/10428199009169604. Leuk Lymphoma. 1990. PMID: 20394563

7

Human lung carcinoma cells engineered to release IL2, IL7, GM-CSF and TNF alpha.

Guarini A, Riera L, Reato G, Carbone A, Cignetti A, Tos A, Lanfrancone L, Melani C, Paul R, Forni G, Foa R. Guarini A, et al. Int J Oncol. 1996 Apr;8(4):765-72. doi: 10.3892/ijo.8.4.765. Int J Oncol. 1996. PMID: 21544424

8

Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.

Richiardi L, Fiano V, Vizzini L, De Marco L, Delsedime L, Akre O, Tos AG, Merletti F. Richiardi L, et al. Among authors: tos ag. J Clin Oncol. 2009 Jul 1;27(19):3161-8. doi: 10.1200/JCO.2008.18.2485. Epub 2009 May 26. J Clin Oncol. 2009. PMID: 19470943 Free article.

9

Seasonality modifies methylation profiles in healthy people.

Ricceri F, Trevisan M, Fiano V, Grasso C, Fasanelli F, Scoccianti C, De Marco L, Tos AG, Vineis P, Sacerdote C. Ricceri F, et al. Among authors: tos ag. PLoS One. 2014 Sep 11;9(9):e106846. doi: 10.1371/journal.pone.0106846. eCollection 2014. PLoS One. 2014. PMID: 25210735 Free PMC article.

10

Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting.

Carozzi FM, Del Mistro A, Confortini M, Sani C, Puliti D, Trevisan R, De Marco L, Tos AG, Girlando S, Palma PD, Pellegrini A, Schiboni ML, Crucitti P, Pierotti P, Vignato A, Ronco G. Carozzi FM, et al. Among authors: tos ag. Am J Clin Pathol. 2005 Nov;124(5):716-21. doi: 10.1309/84E5-WHJQ-HK83-BGQD. Am J Clin Pathol. 2005. PMID: 16203283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters